Correlation Between Aryx Therapeutics and Decibel Cannabis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aryx Therapeutics and Decibel Cannabis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aryx Therapeutics and Decibel Cannabis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aryx Therapeutics I and Decibel Cannabis, you can compare the effects of market volatilities on Aryx Therapeutics and Decibel Cannabis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aryx Therapeutics with a short position of Decibel Cannabis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aryx Therapeutics and Decibel Cannabis.

Diversification Opportunities for Aryx Therapeutics and Decibel Cannabis

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Aryx and Decibel is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Aryx Therapeutics I and Decibel Cannabis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Decibel Cannabis and Aryx Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aryx Therapeutics I are associated (or correlated) with Decibel Cannabis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Decibel Cannabis has no effect on the direction of Aryx Therapeutics i.e., Aryx Therapeutics and Decibel Cannabis go up and down completely randomly.

Pair Corralation between Aryx Therapeutics and Decibel Cannabis

If you would invest  5.14  in Decibel Cannabis on September 1, 2024 and sell it today you would lose (0.66) from holding Decibel Cannabis or give up 12.84% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.79%
ValuesDaily Returns

Aryx Therapeutics I  vs.  Decibel Cannabis

 Performance 
       Timeline  
Aryx Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aryx Therapeutics I has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Aryx Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Decibel Cannabis 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Decibel Cannabis are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental indicators, Decibel Cannabis may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Aryx Therapeutics and Decibel Cannabis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aryx Therapeutics and Decibel Cannabis

The main advantage of trading using opposite Aryx Therapeutics and Decibel Cannabis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aryx Therapeutics position performs unexpectedly, Decibel Cannabis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Decibel Cannabis will offset losses from the drop in Decibel Cannabis' long position.
The idea behind Aryx Therapeutics I and Decibel Cannabis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like